Lidocaton

   
Google
 
Web NewDrugInformation.com

Lidocaton


Drug - Lidocaton
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Lidocaine Hydrochloride
Multiple ingredients are in alphabetical order.

Strength - 2%
The potency of the active ingredient(s), Lidocaine Hydrochloride. May repeat for multiple part products.

Applicant - PHARMATON
The firm name holding legal responsibility for Lidocaton. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 084727
The FDA assigned number to Lidocaton. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Lidocaton. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Aug 17, 1983
The date Lidocaton was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Lidocaton. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Lidocaton is in. Format is RX, OTC, DISCN.

Applicant Full Name - Pharmaton Ltd
The full name of the firm holding legal responsibility for the new application of Lidocaton.

Lidocaton